Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Sanofi-Aventis Ireland Limited T/A SANOFI, Citywest Business Campus, Dublin 24, Ireland
As a mucolytic in the management of viscid mucoid secretions associated with bronchitis, bronchiectasis, sinusitis.
Oral.
Adults and children over 12 years:
Recommended total daily dose: 10 ml (8 mg) three times daily.
Recommended maximum daily dose: 15 ml (12 mg) four times daily.
The recommended maximum daily dose which may be needed at the commencement of treatment should not be exceeded.
Children over 5 to ≤12 years: Recommended total daily dose 5 ml (4 mg) four times daily.
Children 2 to ≤5 years: Recommended total daily dose 5 ml (4 mg) twice daily. The measuring cup provided should be used for dosing. BISOLVON can be taken with or without food (see section 5.2).
BISOLVON Oral Solution is sugar free and therefore suitable for diabetes patients.
No specific overdose symptoms have been reported in man. Based on accidental overdose and/or medication error reports the observed symptoms are consistent with the known side effects of Bisolvon at recommended doses and may need symptomatic treatment.
Unopened: 3 years.
In use: Use within 12 months of opening bottle.
Store in the original container.
Bisolvon Oral Solution is available in amber type III glass bottles with tamper-evident polyethylene caps with low density polyethylene liners. The registered pack sizes are 100 ml, 200 ml, and 250 ml.
Not all pack sizes may be marketed.
A polypropylene measuring dish is provided.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
